Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Paola, Pedotti"'
Autor:
Timo Vesikari, Jerzy Brzostek, Anitta Ahonen, Marita Paassilta, Ewa Majda-Stanislawska, Leszek Szenborn, Miia Virta, Robert Clifford, Teresa Jackowska, Murray Kimmel, Ilaria Bindi, Pavitra Keshavan, Paola Pedotti, Daniela Toneatto
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 11, Pp 4689-4700 (2021)
The meningococcal serogroup B (MenB) protein vaccine, 4CMenB, combined with MenA, MenC, MenW and MenY polysaccharide-protein conjugates for a pentavalent MenABCWY vaccine, can potentially protect against most causative agents of invasive meningococca
Externí odkaz:
https://doaj.org/article/3a81bce5739743bdb0d7b0032b009ef1
Autor:
Sanjay Lalwani, Sharad Agarkhedkar, Nithya Gogtay, Sonali Palkar, Shalaka Agarkhedkar, Urmila Thatte, Hoshang Vakil, Rekha Jonnalagedda, Paola Pedotti, Margaret Hoyle, Chiranjiwi Bhusal, Ashwani Arora
Publikováno v:
International Journal of Infectious Diseases, Vol 38, Iss C, Pp 36-42 (2015)
Background: This phase 3, multi-center, open-label study evaluated the immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACWY-CRM, Menveo®; Novartis Vaccines and Diagnostics S.r.l., Siena, Italy) in healthy Indian subje
Externí odkaz:
https://doaj.org/article/e7357cfc23ef48bab6a6f72f15d4309b
Autor:
Robert Clifford, Murray Kimmel, Ewa Majda-Stanisławska, Jerzy Brzostek, Leszek Szenborn, Ilaria Bindi, Pavitra Keshavan, Marita Paassilta, Paola Pedotti, Timo Vesikari, Teresa Jackowska, Miia Virta, Anitta Ahonen, Daniela Toneatto
The meningococcal serogroup B (MenB) protein vaccine, 4CMenB, combined with MenA, MenC, MenW and MenY polysaccharide-protein conjugates for a pentavalent MenABCWY vaccine, can potentially protect against most causative agents of invasive meningococca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a4911541e5905b01e9aae89225fa8dc
https://trepo.tuni.fi/handle/10024/134688
https://trepo.tuni.fi/handle/10024/134688
Autor:
Mariagabriella Mariani, Wilma Barcellini, Cristina Vercellati, Anna Paola Marcello, Elisa Fermo, Paola Pedotti, Carla Boschetti, Alberto Zanella
Publikováno v:
Haematologica, Vol 93, Iss 9 (2008)
Background Hereditary spherocytosis is a very heterogeneous form of hemolytic anemia. The aim of this study was to relate the type of molecular defect with clinical and hematologic features and response to splenectomy using information from a large d
Externí odkaz:
https://doaj.org/article/9cd02cf3d4a34af290c3c8360cbd9569
Autor:
Jo Anne Welsch, Shelly Senders, Bikash Verma, Daniela Toneatto, Thomas Klein, Silvia Barbi, Igor Smolenov, Paola Pedotti, Brandon Essink
Publikováno v:
Vaccine. 36(35)
Background Neisseria meningitidis serogroups A, B, C, W and Y cause most meningococcal disease worldwide. An investigational MenABCWY vaccine combining serogroup B antigens and a meningococcal ACWY CRM 197 -glycoconjugate vaccine (MenACWY-CRM) could
Autor:
Paola Pedotti, Dorothee Kieninger, H.C. Rumke, Markus Knuf, Giovanni Della Cioppa, Geert Leroux-Roels, Luis Rivera, Maria Lattanzi, Ashwani Kumar Arora
Publikováno v:
Human Vaccines & Immunotherapeutics. 11:358-376
Mass immunization of children has the potential to decrease infection rates and prevent the transmission of influenza. We evaluated the immunogenicity, safety, and tolerability of different formulations of cell-derived MF59-adjuvanted and nonadjuvant
Publikováno v:
Human Vaccines & Immunotherapeutics. 10:2395-2407
During development of an A/H1N1 pandemic influenza vaccine, this study was performed to identify the antigen and adjuvant content which would provide optimal antibody response and persistence in adults and the elderly. Dose-sparing strategies, such a
Autor:
Linda Han, Peter M. Dull, Jo Anne Welsch, Shelly Senders, Randle Middleton, Igor Smolenov, Paola Pedotti
Publikováno v:
Open Forum Infectious Diseases. 3
Autor:
Silvia Musio, Hiroshi Ohtsu, Lawrence Steinman, Louis Boon, Rosetta Pedotti, Renato Mantegazza, Paola Pedotti, Stephen J. Galli
Publikováno v:
Laboratory Investigation. 89:398-405
Induction of T helper 1 (Th1) to Th2 deviation through administration of self- or altered self-peptides holds promise for treatment of autoimmunity. However, administration of self-peptides in models of autoimmunity can result in anaphylactic reactio
Autor:
Margaret Hoyle, Ashwani Kumar Arora, Shalaka Agarkhedkar, Paola Pedotti, Sanjay Lalwani, Urmila M Thatte, Sonali Palkar, Chiranjiwi Bhusal, Hoshang Vakil, Sharad Agarkhedkar, Nithya J Gogtay, Rekha Jonnalagedda
Publikováno v:
International Journal of Infectious Diseases, Vol 38, Iss C, Pp 36-42 (2015)
Summary Background This phase 3, multi-center, open-label study evaluated the immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACWY-CRM, Menveo ® ; Novartis Vaccines and Diagnostics S.r.l., Siena, Italy) in healthy Ind